Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
Clinical trial NCT00989287 · COMPLETED
Trial details
- NCT number
- NCT00989287
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-07
- Primary completion
- 2009-10-09
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.